WOBURN, Mass.--(BUSINESS WIRE)--June 13, 2006--Aphios Corporation today announced that it has been awarded United States Patent No. 7,037,534 B2 for chemiluminescence activated antiviral therapeutics.
WOBURN, Mass.--(BUSINESS WIRE)--June 13, 2006--Aphios Corporation today announced that it has been awarded United States Patent No. 7,037,534 B2 for chemiluminescence activated antiviral therapeutics.